Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Noxxon and Pfizer form Spiegelmer product alliance

March 28, 2006

Genta and Emisphere sign licensing agreement for oral gallium compound

March 28, 2006

Recent patents report new therapeutic agents for metabolic disorders

March 27, 2006

Orphan drug designation for Aastrom's Tissue Repair Cells in osteonecrosis

March 27, 2006

Promising preclinical results with novel oral insulin developed by Terumo

March 24, 2006

Savient and FDA agree on phase III protocol SPA for Puricase

March 23, 2006

Novel antidiabetic agents patented

March 23, 2006

Three new studies evaluate GEM OS1 in orthopedic indications

March 22, 2006

Phase I/II study of obesity drug TM-30338 meets endpoints

March 22, 2006

Rituximab to be studied for type 1 diabetes

March 21, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...